Ondersteunde individuen of organisaties

Oncogene cooperation enhancing TLX1 positive leukemia development

Opportunities of Optical Genome Mapping to detect novel structural and numerical variants in hematologic cancers

A new adoptive T-cell therapy targeting B7-H3 and HMGB1: towards a cure for multiple myeloma

Expanding the immune army: Combatting multiple myeloma using a rational combination of Galsome nanovaccines and immune checkpoint inhibition

Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia.